7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit 72782S from Cell Signaling Technology

Product Specs
Item7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit
CompanyCell Signaling Technology
Price $358.00 Inquire
Catalog Number72782S
Quantity1 Kit
ApplicationsFC-FP
Research AreaRelated Products

Add to Compare List

Cell Signaling Technology

3 Trask Lane

Danvers, Massachusetts 01923

United States

Phone: 877-616-CELL
Phone: 978-867-2388
Fax: 866-432-6112
Fax: 978-867-2488

Company Profile

Website: http://www.cellsignal.com/

Website: Technical Support

(1) Regulating macrophage phenotypes with IL4I1-mimetic nanoparticles in IDD treatmentJournal of nanobiotechnologyMarch 6, 2025Luo J, Jin G, Cui S, Wang H, Liu Q.tissue debris and washed three times in cold PBS. Dead cells stained positive for 7-AAD reagent (CST, 72782 S) were excluded. Subsequently, the cells were co-incubated with FITC-labeled CD45 (BD Biosciences,

(2) LAMTOR1 decreased exosomal PD-L1 to enhance immunotherapy efficacy in non-small cell lung cancerMolecular cancerSeptember 2, 2024Wu B, Huang X, Shi X, Jiang M, Liu H, Zhao L.proliferation experiment, 2 × 105 CD8+ T cells were first incubated with 20 μL CFSE (diluted 1:500) (CST, #72782) at 37 °C for 25 min. Subsequently, anti-CD3/CD28 beads (CST, #70976) and exosomes isolated from treated

(3) CD58 defines regulatory macrophages within the tumor microenvironmentCommunications biologyAugust 21, 2024Wu B, Zhan X, Jiang M.Polyclonal Antibody, APC (1:100; Thermo, PA5-46879); 7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit (CST, #72782); Rapid-Act T Cell Activation Kit (Mouse, Anti-CD3/CD28) (CST, #86772); CD8α (RPA-T8) Mouse mAb (FITC

(4) L-Pampo™, a Novel TLR2/3 Agonist, Acts as a Potent Cancer Vaccine Adjuvant by Activating Draining Lymph Node Dendritic CellsCancersAugust 4, 2023Heo Y, Ko E, Park S, Park SO, Ahn BC, Yum JS, Chun E.columns and the QuadroMACS system (Miltenyi Biotec). Sorted CD3+ T cells were incubated with CFSE (72782, Cell signaling technology, Danvers, MA, USA) at 37 °C for 15 min and washed with DMEM containing 10%

(5) c-Abl inhibits breast cancer tumorigenesis through reactivation of p53-mediated p21 expressionOncotargetNovember 8, 2016Chevaun D. Morrison, Tressa M. Allington, Cheryl L. Thompson, Hannah L. Gilmore, Jenny C. Chang, Ruth A. Keri, William P. SchiemannData are the mean (± SE) of 4 independent experiments as indicated. www.impactjournals.com/oncotarget 72782 Oncotarget p21-deficiency partially restores the tumorigenicity of CST-Abl-expressing 4T1 cells deficient

Be the First to Write a Review!

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit from Cell Signaling Technology

Cell Signaling Technology

Citations (5)

Reviews

7-AAD/CFSE Cell-Mediated Cytotoxicity Assay Kit from Cell Signaling Technology

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map